Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA
Post by: Colleen Parr Dekker
Greenfield, Indiana, USA. (Wednesday, 27 January 2016) – Today at Elanco Animal Health, a subsidiary of Eli Lilly & Co. (LLY), we informed our workforce that we have made the business decision to exit ownership of our Dundee manufacturing operations.
The difficult decision was reached as part of an in-depth evaluation of our global manufacturing operations, allowing Elanco to maintain a competitive advantage in the continually changing animal health business. It is in no way a reflection of site performance at Dundee. The evaluation has also resulted in the decision to close our manufacturing site in Sligo, Ireland.
Over the coming months, one of our top priorities will be to seek a buyer for ongoing manufacturing operations at the site. The site will operate as normal during this time – continuing to deliver a safe, high-quality, reliable supply to customers. If efforts to find a suitable buyer are unsuccessful, we will commence the transfer of product supply to other manufacturing sites, leading to a site closure. If this were to occur, the company anticipates the transition of production would take approximately two years to complete.
As part of the announcement, some global support roles at Dundee will transition out of the site in 2016 and would not be part of a potential site sale.This transition, affecting about 30 positions, will commence shortly. The affected employees will enter a formal consultation period from mid-February to help them understand the changes and to examine options available to them.
Elanco understands this announcement will generate uncertainty and concern among employees. The company is sensitive to the needs of employees and will keep them informed throughout the process.
Elanco provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries around the world. We value innovation, both in scientific research and daily operations, and strive to cultivate a collaborative work environment for more than 6,500 employees worldwide. Together with our customers, we are committed to raising awareness about global food security, and celebrating and supporting the human-animal bond. Founded in 1954, Elanco is a division of Eli Lilly and Company. Our worldwide headquarters and research facilities are located in Greenfield, Indiana. Visit us at Elanco.com and EnoughMovement.com.
0754 000 2134
Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 64-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.